3+ hour, 1+ min ago   (741+ words) Massachusetts Biotechnology Council Scientific breakthroughs have the power to change lives, but science itself is not the only contributor to their impact. The 2026 BiotechTV U.S. Science Summit, presented by title sponsors MassBio and BIO, brought together biotech leaders, researchers, investors and…...

4+ hour, 34+ min ago   (587+ words) MassBio CEO & President Kendalle Burlin O’Connell originally posted this update to LinkedIn. Washington is clearing its desk before August recess. The Senate has stacked a final round of hearings, including several in the biotech space, the SEC sent Congress its…...

2+ day, 3+ hour ago   (186+ words) Guest Blog by Jeff Goldman, General Manager, Ensorcell Innovation should not be limited by the cost of the tools required to create it. So how can the industry accelerate scientific innovation while lowering unnecessary costs throughout the research and manufacturing…...

6+ day, 6+ hour ago   (336+ words) By Jon Chesto and Shirley Leung, Boston Globe The following is an excerpt from Jon Chesto and Shirley Leung’s Power Play newsletter on July 23, 2026: Now, head up to the 40th floor at 53 State St. Drop in on Jeff Leerink and his…...

1+ week, 4+ hour ago   (880+ words) Several announcements this week made plain that maintaining U.S. leadership in biotechnology is a top administration priority, and that AI is the tool it intends to use to secure it. Across OSTP, HHS, and FDA, the same themes recurred: compressing development…...

2+ week, 3+ day ago   (192+ words) The following is an excerpt from the BioWorld story, “SEC reform good for life sciences startups, but getting pushback,” published on July 8, 2026 and authored by Mari Serebrov. Of all the U.S. SEC’s recent proposed rules to make going, and…...

3+ week, 3+ hour ago   (397+ words) E&C Kicks Off the Road to PDUFA VIII: The House Energy and Commerce Health Subcommittee holds a hearing Wednesday, July 15 at 10:15 a.m. titled Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development. The session will examine…...

1+ mon, 5+ day ago   (650+ words) Massachusetts Biotechnology Council It was a consequential week for federal policy. Operation TrialBlazer is the kind of reform MassBio and our members have long pressed for to fight for American leadership in first-in-human trials. Leadership matters in moving the Massachusetts…...

1+ mon, 2+ week ago   (636+ words) From NIH grant caps to FY27 appropriations to a landmark biosecurity push, this week’s policy developments touch every corner of our ecosystem. A few things worth knowing. NIH Floats Cap on Simultaneous Grants Per Investigator: On June 8, NIH released a Request…...

1+ mon, 3+ week ago   (774+ words) A busy week in Washington with real consequences for Massachusetts — from new legislation putting biotech licensing deals under national security review, to a sweeping OMB proposal that would hand political appointees veto power over scientific peer review. Here’s what we’re…...